• Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • EU Focus
    • Regulatory Affairs
    • Business & Policies
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us
Login Area

Members Area

 

Follow Us
Facebook
Twitter
LinkedIn
YouTube
Slideshare
EIPG Logo
  • Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • EU Focus
    • Regulatory Affairs
    • Business & Policies
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us

EIPG Feedback on proposed GMP Guidelines

The European Commission recently launched a public consultation on a Commission Delegated Act on principles and guidelines on good manufacturing practice for investigational medicinal products and on inspection procedures, pursuant to the first subparagraph of Article 63(1) of Regulation (EU) No 536/2014 and Detailed Commission guidelines on good manufacturing practice for investigational medicinal products for human use, pursuant to the second subparagraph of Article 63(1) of Regulation (EU) No 536/2014. EIPG has reviewed the documents and. following feedback from its members, has submitted its comments on the Commission.

Read the EIPG Feedback on the proposed Commission Delegated Act and GMP Guidelines.

  • In memory of John Jolley
    • April 24, 2025
  • EMA guideline on investigational ATMPs
    • April 24, 2025
  • The proposal of a Critical Medicines Act
    • April 4, 2025
  • EIPG Webinar | The Cumulative Impact of Environment and Chemical Legislation and the future of the Healthcare Sector | Kirsty Reid
    • March 25, 2025
  • The Clean Industrial Deal and the Omnibus package on simplification
    • March 25, 2025
  • The FDA’s Advanced Manufacturing Technologies Designation Program
    • March 9, 2025
  • The EU’s Competitiveness Compass and the new EU Biotech Hub
    • February 21, 2025
  • The EU AI Act: compliance obligations and business opportunities in 2025
    • February 17, 2025
  • PIC/S’ new guidances on remote and hybrid inspections
    • February 5, 2025
  • ICH E6(R3): a new era for Good Clinical Practice in industrial pharmacy
    • January 31, 2025
EU Transparency Register
EIPG is registered in the EU
Transparency Register with public ID
number 979567925318-36

0
0
0
33
0
Disclaimer and Privacy Policy
  • Privacy Policy
  • Disclaimer
Contacts
  • General Inquiries
  • President
  • Executive Director
  • Vice-President Communications